How Data for ImmunoGen Drug Could the Way Doctors Treat Ovarian Cancer
In a confirmatory Phase 3 test of ImmunoGen’s Elahere, the ovarian cancer drug handily beat chemotherapy with results that clinicians say could make the treatment the new standard of care for certain patients. The data were presented during the annual meeting of the American Society of Clinical Oncology.
Source: medcitynews.com